These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30254847)

  • 1. Tenofovir-induced renal tubular dysfunction among human immunodeficiency virus patients on antiretroviral therapy in Nigeria: Prospects for early detection of presymptomatic nephrotoxicity.
    Obiebi IP; Nwannadi EA
    Kidney Res Clin Pract; 2018 Sep; 37(3):230-238. PubMed ID: 30254847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe.
    Mashingaidze-Mano R; Bwakura-Dangarembizi MF; Maponga CC; Morse GD; Monera-Penduka TG; Mtisi TJ; Mudzviti T; Mujuru HA
    PLoS One; 2020; 15(7):e0235759. PubMed ID: 32634168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early switching of tenofovir disoproxil fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: a prospective study.
    Patamatamkul S; Songumpai N; Payoong P; Katavetin P; Putcharoen O
    HIV Res Clin Pract; 2022 Aug; 23(1):99-106. PubMed ID: 36065999
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study.
    Jotwani V; Scherzer R; Estrella MM; Jacobson LP; Witt MD; Palella FJ; Macatangay B; Bennett M; Parikh CR; Ix JH; Shlipak MG
    Am J Kidney Dis; 2016 Oct; 68(4):571-581. PubMed ID: 27287300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients.
    Gallant JE; Winston JA; DeJesus E; Pozniak AL; Chen SS; Cheng AK; Enejosa JV
    AIDS; 2008 Oct; 22(16):2155-63. PubMed ID: 18832879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Highly Active Antiretroviral Therapy on Renal Function and Renal Phosphate Handling in African Adults with Advanced HIV and CKD.
    Adedeji TA; Adebisi SA; Adedeji NO; Biliaminu SA; Olanrewaju TO
    Infect Disord Drug Targets; 2019; 19(1):88-100. PubMed ID: 30027856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
    Rodríguez-Nóvoa S; García-Samaniego J; Prieto M; Calleja JL; Pascasio JM; Delgado Blanco M; Crespo J; Buti M; Bonet Vidal ML; Arenas Ruiz Tapiador J; Fernández-Rodríguez C; Solá R; Fraga E; González Diéguez L; Núñez O; Praga M; Del Pino-Montes J; Romero-Gómez M; Morillas R; Diago M; Castro Á;
    J Clin Gastroenterol; 2016 Oct; 50(9):779-89. PubMed ID: 27332746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients.
    Seo JW; Kim K; Jun KI; Kang CK; Moon SM; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Choe PG; Park WB; Oh MD
    Infect Chemother; 2020 Sep; 52(3):381-388. PubMed ID: 32757496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
    AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
    Mugwanya K; Baeten J; Celum C; Donnell D; Nickolas T; Mugo N; Branch A; Tappero J; Kiarie J; Ronald A; Yin M; Wyatt C;
    J Infect Dis; 2016 Oct; 214(7):1050-7. PubMed ID: 27029778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and European AIDS Clinical Society (EACS) criteria evaluation for proximal renal tubular dysfunction diagnosis in patients under antiretroviral therapy in routine setting.
    Pitisci L; Demeester R; Legrand JC
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19564. PubMed ID: 25394071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors for tenofovir-associated nephrotoxicity among human immunodeficiency virus-infected patients in Korea.
    Lee JE; Lee S; Song SH; Kwak IS; Lee SH
    Korean J Intern Med; 2019 Mar; 34(2):409-417. PubMed ID: 29020764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary β2 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy.
    Nishijima T; Kurosawa T; Tanaka N; Kawasaki Y; Kikuchi Y; Oka S; Gatanaga H
    AIDS; 2016 Jun; 30(10):1563-71. PubMed ID: 26919734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.
    Izzedine H; Hulot JS; Vittecoq D; Gallant JE; Staszewski S; Launay-Vacher V; Cheng A; Deray G;
    Nephrol Dial Transplant; 2005 Apr; 20(4):743-6. PubMed ID: 15741212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal safety of tenofovir disoproxil fumarate and entecavir with hepatitis B immunoglobulin in liver transplant patients.
    Lee J; Park JY; Yang SJ; Lee JY; Kim DG; Joo DJ; Kim MS; Kim SI; Lee JG
    J Viral Hepat; 2020 Aug; 27(8):818-825. PubMed ID: 32302037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
    Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
    AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of tenofovir and renal disease for the HIV-treating clinician.
    Venter WDF; Fabian J; Feldman C
    South Afr J HIV Med; 2018; 19(1):817. PubMed ID: 30167339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury.
    Samuels R; Bayerri CR; Sayer JA; Price DA; Payne BAI
    AIDS; 2017 Jun; 31(9):1297-1301. PubMed ID: 28323756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
    AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
    Casado JL; Santiuste C; Vivancos MJ; Monsalvo M; Moreno A; Perez-Elías MJ; Del Rey JM; Moreno S
    HIV Med; 2018 Jun; ():. PubMed ID: 29932293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.